LEADER 01591oam  2200469   450 
001 9910713729403321
005 20210720140840.0
035   $a(CKB)5470000002504392
035   $a(OCoLC)1183029890
035   $a(EXLCZ)995470000002504392
100   $a20200810d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExpanding Findings for Federal Opioid Research and Treatment Act $ereport of the Committee on Commerce, Science, and Transportation on H.R. 3153
210  1$aWashington :$cU.S. Government Publishing Office,$d2020.
215   $a1 online resource (ii, 5 pages)
225 1 $aReport / 116th Congress, 2d session, Senate ;$v116-248
300   $a"August 6, 2020."
320   $aIncludes bibliographical reference.
517   $aExpanding Findings for Federal Opioid Research and Treatment Act 
606   $aOpioids$xResearch$zUnited States
606   $aOpioid abuse$xTreatment$zUnited States
606   $aOpioid abuse$xTreatment$2fast
607   $aUnited States$2fast
608   $aLegislative materials.$2fast
608   $aLegislative materials.$2lcgft
615  0$aOpioids$xResearch
615  0$aOpioid abuse$xTreatment
615  7$aOpioid abuse$xTreatment.
801  0$bGPO
801  1$bGPO
801  2$bDWP
801  2$bGPO
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910713729403321
996   $aExpanding Findings for Federal Opioid Research and Treatment Act$93448145
997   $aUNINA